Literature DB >> 18199212

Development of an ovine model of myocardial infarction.

Shahram Rabbani1, Hossein Ahmadi, Ehsan Fayazzadeh, Mohammad Sahebjam, Mohammad A Boroumand, Maryam Sotudeh, Seyed Mahdi Nassiri.   

Abstract

BACKGROUND: We report experimental myocardial infarction by occluding coronary arteries in ovine models.
METHODS: Twelve ewes were included in the study. After the chest was opened by left lateral thoracotomy incision, the second diagonal branch of the left anterior descending coronary artery was ligated at a point approximately 40% distant from its base. Prophylactic anti-arrhythmics were given. Animals were mechanically ventilated during surgery and stayed in intensive care unit for 24 h postoperation. Experiments were then evaluated by echocardiographic, electrocardiographic, haemodynamic, serological and morphological investigations. Echocardiographic measurements were repeated after 2 months and animals were then killed for post-mortem cardiac examinations.
RESULTS: All animals survived the surgical procedure. Cyanotic discoloration and hypokinesia in the cardiac tissue in an area of (30 +/- 2) x (4 +/- 2) mm plus ST-segment elevations was detected immediately after vessel ligation. Moreover, there were pathological Q-waves 2 months later. Echocardiographic evaluations showed an average of 30% relative decrease in cardiac ejection fraction. Wall motion analysis showed anteroseptal hypokinesia and akinesia in all animals 1 day and 2 months after operation, respectively. Thin-walled infarcted areas with tissue fibrosis were evident in pathological investigations 2 months after surgery.
CONCLUSION: In conclusion, we developed a practical and safe method for producing myocardial infarction in large animal models.

Entities:  

Mesh:

Year:  2008        PMID: 18199212     DOI: 10.1111/j.1445-2197.2007.04359.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

Review 1.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

Review 2.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

3.  Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.

Authors:  Tieluo Li; Xufeng Wei; A Claire Watkins; Pablo G Sanchez; Zhongjun J Wu; Bartley P Griffith
Journal:  J Surg Res       Date:  2013-06-07       Impact factor: 2.192

4.  Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells.

Authors:  Christopher D Porada; Duygu D Harrison-Findik; Chad Sanada; Vincent Valiente; David Thain; Paul J Simmons; Graça Almeida-Porada; Esmail D Zanjani
Journal:  Exp Hematol       Date:  2008-12       Impact factor: 3.084

5.  Effects of Endothelial and Mesenchymal Stem Cells on Improving Myocardial Function in a Sheep Animal Model.

Authors:  Shahram Rabbani; Masoud Soleimani; Mohammad Sahebjam; Mohammad Imani; Seyed Mahdi Nassiri; Amir Atashi; Morteza Daliri Joupari; Ali Ghiaseddin; Mostafa Latifpour; Seyed Hossein Ahmadi Tafti
Journal:  J Tehran Heart Cent       Date:  2017-04

Review 6.  Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models.

Authors:  Stefan Michael Sattler; Lasse Skibsbye; Dominik Linz; Anniek Frederike Lubberding; Jacob Tfelt-Hansen; Thomas Jespersen
Journal:  Front Cardiovasc Med       Date:  2019-11-05

7.  A nonthoracotomy myocardial infarction model in an ovine using autologous platelets.

Authors:  Tyler Spata; Daniel Bobek; Bryan A Whitson; Sampath Parthasarathy; Peter J Mohler; Robert S D Higgins; Ahmet Kilic
Journal:  Biomed Res Int       Date:  2013-12-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.